Login to Your Account

Clinic Roundup

Tuesday, August 27, 2013
Kempharm Inc., of North Liberty, Iowa, disclosed positive results from one of several clinical and nonclinical studies that the company is performing in preparation for its new drug application for KP201 (benzhydrocodone and acetaminophen), which the company anticipates filing in the second quarter of 2014.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription